Southern Oncology Clinical Research Unit
Adelaide, South Australia, Australia
10 recruiting
Showing 1–18 of 18 trials
Recruiting
Phase 1Phase 2
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
HER2-Positive Solid Tumor
Yuhan Corporation147 enrolled19 locationsNCT05523947
Recruiting
Phase 1
First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors
Solid Tumors (Phase 1)
Adcendo ApS180 enrolled7 locationsNCT07362888
Recruiting
Phase 2
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Ovarian Cancer
Incyte Corporation160 enrolled79 locationsNCT07023627
Recruiting
Phase 1Phase 2
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Advanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Esophageal Squamous Cell Carcinoma+4 more
Hummingbird Bioscience398 enrolled20 locationsNCT05910827
Recruiting
Phase 1Phase 2
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc.159 enrolled18 locationsNCT05267626
Recruiting
Phase 1
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Solid Tumors
Boehringer Ingelheim190 enrolled40 locationsNCT05155332
Recruiting
Phase 1Phase 2
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Advanced Solid Tumors CancerMSI-H Cancer
Nimbus Wadjet, Inc.134 enrolled22 locationsNCT06898450
Recruiting
Phase 1
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Advanced Solid Tumor
Adcendo ApS210 enrolled11 locationsNCT06597721
Recruiting
Phase 1
Study of BM230 in Patients With Advanced Solid Tumors
Solid Tumor
Suzhou Biomissile Pharmaceuticals Co., Ltd.123 enrolled6 locationsNCT06644300
Recruiting
Phase 2
A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer Survivors
Cancer SurvivorsHealthy ParticipantElderly
GI Innovation, Inc.15 enrolled2 locationsNCT07363057
Recruiting
Phase 1
Trial of INI-4001 in Patients With Advanced Solid Tumours
Advanced Solid Tumor
Inimmune Corporation50 enrolled3 locationsNCT06302426
Recruiting
Phase 1
A Study of DM002 in Patients With Advanced Solid Tumors
Ovarian NeoplasmsProstatic NeoplasmsEndometrial Neoplasms+2 more
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.160 enrolled5 locationsNCT06751329
Recruiting
Phase 1
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Atridia Pty Ltd.25 enrolled11 locationsNCT06830850
Recruiting
Phase 1
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple-Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc.168 enrolled16 locationsNCT06022029
Recruiting
Phase 1
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
Solid Tumor
IDEAYA Biosciences180 enrolled39 locationsNCT04794699
Recruiting
Phase 1
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Gastrointestinal CancerCholangiocarcinomaLiver Cancer+6 more
Arbele Pty Ltd68 enrolled3 locationsNCT05411133
Recruiting
Phase 1
AMT-116 in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Multitude Therapeutics Inc.80 enrolled10 locationsNCT05725291
Recruiting
Phase 1
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors
Locally Advanced or Metastatic Solid Tumors
Antengene Therapeutics Limited98 enrolled7 locationsNCT05205109